<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39465828</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>41</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Neutrophil-platelet ratio as a predictor of acute kidney injury in severe COVID-19.</ArticleTitle><Pagination><StartPage>e40053</StartPage><MedlinePgn>e40053</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40053</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000040053</ELocationID><Abstract><AbstractText>Acute kidney injury (AKI) is one of the most seen complications of coronavirus-2019 (COVID-19) infection. Patients with AKI caused by COVID-19 likely have higher neutrophil counts and lower platelet and lymphocyte levels. Therefore, the predictive value of many inflammation indexes calculated from the total blood count has been investigated to predict the AKI in COVID-19. According to our clinical experience, we thought that neutrophilia and thrombocytopenia may be more common in the development of AKI. For this reason, this study aimed to evaluate the predictive value of the neutrophil-to-platelet ratio (NPR) for AKI in severe COVID-19 patients. This retrospective study included 334 severe COVID-19 patients followed up in the intensive care unit (ICU). Predictive factors for AKI were analyzed. ROC curve analysis was performed to determine the inflammation indexes' cutoff values for the AKI prediction. Multivariate analyses were performed to determine correlations between the inflammation indexes and AKI. In this study, AKI was determined at the rate of 43% (n:145). Independent risk factors affecting AKI were determined to be age (HR = 1.047, 95% confidence interval [CI]: 1.021-1.072, P &lt; .001), the need for invasive mechanical ventilation (HR = 3.003, 95% CI: 1.645-5.481, P = .001) and the need for vasopressor (HR = 8.111, 95% CI: 3.786-17.375, P &lt; .001). The optimal cutoff values predicting AKI were determined to be 3.9 for the NPR (AUC = 0.679, 95% CI: 0.622-0.737, P &lt; .001) with 71.7% sensitivity and 61.9% specificity, 16.1 for the neutrophil-to-lymphocyte ratio (NLR) (AUC = 0.634, 95% CI: 0.575-0.694, P &lt; .001) with 65.5% sensitivity and 56.1% specificity, and 3872.5 × 109L for the systemic inflammatory index (SII) (AUC = 0.566, 95% CI: 0.504-0.629, P = .038) with 60% sensitivity and 55.6% specificity. In the regression model, only NPR values above the cutoff were related to AKI (HR = 3.817, 95% CI: 1.782-8.177, P = .001). The NPR has more predictive value than the NLPR, NLR, and SII in developing AKI in severe COVID-19 patients in the ICU. NPR is a new helpful index that can help clinicians predict early AKI in critical COVID-19.</AbstractText><CopyrightInformation>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sayan</LastName><ForeName>Mihrican</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3469-7139</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Lapseki State Hospital, Canakkale, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altinisik</LastName><ForeName>Hatice Betul</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Beykent University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayan</LastName><ForeName>Ozan</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Reanimation, Canakkale Onsekiz Mart University, Canakkale, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="Y">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001792" MajorTopicYN="N">Blood Platelets</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39465828</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000040053</ArticleId><ArticleId IdType="pii">00005792-202410110-00046</ArticleId><ArticleId IdType="pmc">PMC11479445</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, et al. . China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JH, Hirsch JS, Hazzan A, et al. . Northwell Nephrology COVID-19 Research Consortium. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis. 2021;77:204–15.e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833189</ArticleId><ArticleId IdType="pubmed">32961245</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bell S, Forni L, et al. . Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17:751–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256398</ArticleId><ArticleId IdType="pubmed">34226718</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, et al. . Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829–38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395:1054–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Du X, Chen J, et al. . Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6–e12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195072</ArticleId><ArticleId IdType="pubmed">32283162</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaaslan T, Karaaslan E. Predictive value of systemic immune-inflammation index in determining mortality in COVID-19 Patients. J Critical Care Med (Universitatea de Medicina si Farmacie din Targu-Mures). 2022;8:156–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9396947</ArticleId><ArticleId IdType="pubmed">36062039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo E, Maldonado IL, Razo MA, Martinez GV, Lopez S. Association of Neutrophil/Lymphocyte Ratio and Neutrophil/Lymphocyte Platelet Ratio with acute kidney injury in severe COVID-19. Cureus. 2023;15:e43873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511298</ArticleId><ArticleId IdType="pubmed">37736444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, et al. . Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31:e2176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7646060</ArticleId><ArticleId IdType="pubmed">33022818</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO Clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179–84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD. Pathophysiology and pathology of acute kidney injury in patients with COVID-19. Adv Chronic Kidney Dis. 2020;27:365–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574722</ArticleId><ArticleId IdType="pubmed">33308501</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai TR, Leeper NJ, Hynes KL, Gewertz BL. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C Pathway. J Surg Res. 2002;104:118–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">12020130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalmurti N, Hunter CA. Cytokine COVID-19. Immunity. 2020;53:19–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321048</ArticleId><ArticleId IdType="pubmed">32610079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, To KKW, Wong YC, et al. . Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses. Immunity. 2020;53:864–77.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402670</ArticleId><ArticleId IdType="pubmed">32791036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, et al. . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. . Hematological findings and complications of COVID-19. Am J Hematol. 2020;95:834–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Houston DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematology Am Soc Hematol Educ Program. 2017;2017:660–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142536</ArticleId><ArticleId IdType="pubmed">29222318</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson DR, Lesur O, Tétrault JP, Nault V, Pilon D. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Can J Anaesth. 2013;60:641–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23615940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin. Chim. Acta. 2020;506:145–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102663</ArticleId><ArticleId IdType="pubmed">32178975</ArticleId></ArticleIdList></Reference><Reference><Citation>Samra T, Ramachandran R, Kumar V, et al. . Biochemical predictors of acute kidney injury in critically Ill COVID-19 patients. OMICS. 2022;26:650–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36454181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameiro J, Fonseca JA, Oliveira J, et al. . Acute kidney injury in hospitalized patients with COVID-19: a Portuguese cohort. Nefrologia. 2021;41:689–98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800378</ArticleId><ArticleId IdType="pubmed">36165158</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Kuo G, Fan PC, et al. . Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study. J Nephrol. 2022;35:911–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8498757</ArticleId><ArticleId IdType="pubmed">34623629</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevinc C, Demirci R, Timur O. Predicting hospital mortality in COVID-19 hemodialysis patients with developed scores. Semin Dial. 2021;34:347–59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447133</ArticleId><ArticleId IdType="pubmed">34318946</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras Chávez M, Bravo Santibáñez E, Hernández González MA, López Briones S, González Carrillo PL. Relación neutrófilos, linfocitos y plaquetas como predictor de lesión renal aguda en sepsis por COVID-19 en la Unidad de Cuidados Intensivos. Medicina Crítica. 2022;36:14–21.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>